Repeatability and Reproducibility of Cirrus HD-OCT Macular Retinal Pigment Epithelium Elevation

Completed

Conditions studied: Dry AMD With Macular Drusen

In brief

The objective of this study is to determine the repeatability and reproducibility of the Cirrus HD-OCT measurements of drusen area and volume.

Key facts

Study ID

NCT01890174

Run by

Carl Zeiss Meditec, Inc.

People needed

54

Starts

2011-02-01

Expected to finish

2011-06-01

Last updated by the study team

2013-07-01

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males or females 50 years of age or older diagnosed to have dry AMD with macular drusen.
• Drusen should not be combined with other lesions such as geographic atrophy (GA) or choroidal neovascularization.
• Able and willing to make the required study visits.
• Able and willing to give consent and follow study instructions.

You may not qualify if…

• History of retinal surgery, laser photocoagulation, and/or radiation therapy to the eye.
• Evidence of other retinal diseases of the eye, including wet AMD, diabetic retinopathy, diabetic macular edema, or significant vitreomacular traction.
• Thick media opacity or inability to fixate that precludes obtaining acceptable scans.
• Concomitant use of hydrochloroquine or chloroquine.
• Unable to make the required study visits.
• Unable to give consent or follow study instructions.

Where it is running

• Northern California Retina Vitreous Associates — Mountain View, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.